CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale President and COO sold 179,703 shares at an average $13.21 ($2,374,058)
- 4 Open-market sale Director sold 15,394 shares at $13.91 ($214,131)
- 4 Planned sale Chief People Officer sold 30,593 shares at $14.08 ($430,749)
- 4 Open-market sale Chief Commercial Officer, MRD sold 41,338 shares at $13.17 ($544,421)
- 4 Open-market sale Chief Commercial Ofc Imm Med sold 63,103 shares at $13.17 ($831,067)
- 4 Open-market sale Chief Financial Officer sold 18,672 shares at $13.17 ($245,910)
- 4 Open-market sale Chief Scientific Officer sold 470,266 shares at $13.17 ($6,193,403)
- 4 Open-market sale CEO and Chairman sold 470,167 shares at $13.17 ($6,192,099)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale President and COO sold 81,342 shares at an average $14.90 ($1,211,737)
- 144 Insider Sale of Securities
- 4 Open-market sale Chief People Officer sold 38,074 shares at $15.09 ($574,537)
- 4 Grant or award Director acquired 15,625 shares (grant or award)
- 4 Grant or award Director acquired 15,625 shares (grant or award)
Page 6 of 42 · 836 filings